NCT06790849Completed
ETASCAI Pilot Project
The Impact of Chronic Consumption of ETAS® for 12 Weeks on Cognitive, Affective, and Inflammatory Outcomes: A Randomised Parallel Group Placebo-controlled Feasibility Study
Source: ClinicalTrials.gov · Last updated 19 Nov 2025
Brief summary (registry, in English)
This pilot study aims to investigate the chronic effects of ETAS® on cognitive, affective and inflammatory outcomes in healthy adults aged 60-80 years with mild to moderate subjective cognitive complaints.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 45 (actual)
- First submitted
- 13 Jan 2025
- Start date
- 24 Feb 2025
- Primary completion date
- 22 Oct 2025
- Lead sponsor
- University of Reading
- NCT number
- NCT06790849
What you commit to
- Study type: Interventional
- Participants enrolled: 45
- From 24 Feb 2025 to the primary completion date, 22 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently taking anticoagulants, antiplatelet medication, antidepressants, proton-pump inhibitors
- Continuous antibiotic use for \> 3 days within 1 month prior to enrolment
- Continuous use of weight-loss drug for \> 1 month before screening
Other illness
- Having food allergies or intolerances
- Being diagnosed with any psychiatric or neurologic conditions (e.g. schizophrenia, depression, dementia) including eating disorders
- Being diagnosed with any cardiometabolic diseases (including type II diabetes and cardiovascular disease), or suffering from hypertension or thrombosis related disorders or suffer from thyroid disease
- Having inflammatory bowel disease; coeliac disease; total colectomy or bariatric surgery; irritable bowel disease; end stage renal disease; active cancer, or treatment for any cancer, in last 3 years
Other
- Smoking
- Following restrictive and/or unbalanced diets
- Changing dietary intake majorly in past month
- Being anaemic
- Currently consuming prebiotic or probiotic supplements
Who the study is looking for
- Aging between 60-80 years old
- Having normal vision and hearing
- Having a body mass index between 18.5 and 30
- Having mild to moderate subjective cognitive complaints
Age in the registry: 60 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Reading, School of Psychology and Clinical Languages Coordinator of this site? Confirm its status | Reading | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.